These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

382 related items for PubMed ID: 20886185

  • 21. Apixaban versus enoxaparin for thromboprophylaxis after knee replacement (ADVANCE-2): a randomised double-blind trial.
    Lassen MR, Raskob GE, Gallus A, Pineo G, Chen D, Hornick P, ADVANCE-2 investigators.
    Lancet; 2010 Mar 06; 375(9717):807-15. PubMed ID: 20206776
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Rivaroxaban for thromboprophylaxis after orthopaedic surgery: pooled analysis of two studies.
    Fisher WD, Eriksson BI, Bauer KA, Borris L, Dahl OE, Gent M, Haas S, Homering M, Huisman MV, Kakkar AK, Kälebo P, Kwong LM, Misselwitz F, Turpie AG.
    Thromb Haemost; 2007 Jun 06; 97(6):931-7. PubMed ID: 17549294
    [Abstract] [Full Text] [Related]

  • 24. Safety and efficacy of edoxaban, an oral factor Xa inhibitor, versus enoxaparin for thromboprophylaxis after total knee arthroplasty: the STARS E-3 trial.
    Fuji T, Wang CJ, Fujita S, Kawai Y, Nakamura M, Kimura T, Ibusuki K, Ushida H, Abe K, Tachibana S.
    Thromb Res; 2014 Dec 06; 134(6):1198-204. PubMed ID: 25294589
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Comparison of the oral direct thrombin inhibitor ximelagatran with enoxaparin as prophylaxis against venous thromboembolism after total knee replacement: a phase 2 dose-finding study.
    Heit JA, Colwell CW, Francis CW, Ginsberg JS, Berkowitz SD, Whipple J, Peters G, AstraZeneca Arthroplasty Study Group.
    Arch Intern Med; 2001 Oct 08; 161(18):2215-21. PubMed ID: 11575978
    [Abstract] [Full Text] [Related]

  • 28. Prevention of venous thromboembolic disease following primary total knee arthroplasty. A randomized, multicenter, open-label, parallel-group comparison of enoxaparin and warfarin.
    Fitzgerald RH, Spiro TE, Trowbridge AA, Gardiner GA, Whitsett TL, O'Connell MB, Ohar JA, Young TR, Enoxaparin Clinical Trial Group.
    J Bone Joint Surg Am; 2001 Jun 08; 83(6):900-6. PubMed ID: 11407799
    [Abstract] [Full Text] [Related]

  • 29. Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer.
    Bergqvist D, Agnelli G, Cohen AT, Eldor A, Nilsson PE, Le Moigne-Amrani A, Dietrich-Neto F, ENOXACAN II Investigators.
    N Engl J Med; 2002 Mar 28; 346(13):975-80. PubMed ID: 11919306
    [Abstract] [Full Text] [Related]

  • 30. Apixaban versus enoxaparin for thromboprophylaxis in medically ill patients.
    Goldhaber SZ, Leizorovicz A, Kakkar AK, Haas SK, Merli G, Knabb RM, Weitz JI, ADOPT Trial Investigators.
    N Engl J Med; 2011 Dec 08; 365(23):2167-77. PubMed ID: 22077144
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. [Venous thromboembolism prophylaxis after total hip arthroplasty].
    Kučera T, Malý R, Urban K, Sponer P.
    Acta Chir Orthop Traumatol Cech; 2011 Dec 08; 78(2):101-5. PubMed ID: 21575551
    [Abstract] [Full Text] [Related]

  • 33. Comparison of ximelagatran with warfarin for the prevention of venous thromboembolism after total knee replacement.
    Francis CW, Berkowitz SD, Comp PC, Lieberman JR, Ginsberg JS, Paiement G, Peters GR, Roth AW, McElhattan J, Colwell CW, EXULT A Study Group.
    N Engl J Med; 2003 Oct 30; 349(18):1703-12. PubMed ID: 14585938
    [Abstract] [Full Text] [Related]

  • 34. Interpretation of benefit-risk of enoxaparin as comparator in the RECORD program: rivaroxaban oral tablets (10 milligrams) for use in prophylaxis in deep vein thrombosis and pulmonary embolism in patients undergoing hip or knee replacement surgery.
    Van Thiel D, Kalodiki E, Wahi R, Litinas E, Haque W, Rao G.
    Clin Appl Thromb Hemost; 2009 Oct 30; 15(4):389-94. PubMed ID: 19608550
    [Abstract] [Full Text] [Related]

  • 35. A dose-ranging study of the oral direct thrombin inhibitor, ximelagatran, and its subcutaneous form, melagatran, compared with dalteparin in the prophylaxis of thromboembolism after hip or knee replacement: METHRO I. MElagatran for THRombin inhibition in Orthopaedic surgery.
    Eriksson BI, Arfwidsson AC, Frison L, Eriksson UG, Bylock A, Kälebo P, Fager G, Gustafsson D.
    Thromb Haemost; 2002 Feb 30; 87(2):231-7. PubMed ID: 11858482
    [Abstract] [Full Text] [Related]

  • 36. Extended-duration thromboprophylaxis with enoxaparin after arthroscopic surgery of the anterior cruciate ligament: a prospective, randomized, placebo-controlled study.
    Marlovits S, Striessnig G, Schuster R, Stocker R, Luxl M, Trattnig S, Vécsei V.
    Arthroscopy; 2007 Jul 30; 23(7):696-702. PubMed ID: 17637403
    [Abstract] [Full Text] [Related]

  • 37. Fondaparinux for prevention of venous thromboembolism in major orthopedic surgery.
    Tran AH, Lee G.
    Ann Pharmacother; 2003 Nov 30; 37(11):1632-43. PubMed ID: 14565815
    [Abstract] [Full Text] [Related]

  • 38. Apixaban versus enoxaparin in patients with total knee arthroplasty. A meta-analysis of randomised trials.
    Huang J, Cao Y, Liao C, Wu L, Gao F.
    Thromb Haemost; 2011 Feb 30; 105(2):245-53. PubMed ID: 20941455
    [Abstract] [Full Text] [Related]

  • 39. Rivaroxaban for the prevention of venous thromboembolism after hip or knee arthroplasty. Pooled analysis of four studies.
    Turpie AG, Lassen MR, Eriksson BI, Gent M, Berkowitz SD, Misselwitz F, Bandel TJ, Homering M, Westermeier T, Kakkar AK.
    Thromb Haemost; 2011 Mar 30; 105(3):444-53. PubMed ID: 21136019
    [Abstract] [Full Text] [Related]

  • 40. Enoxaparin plus compression stockings compared with compression stockings alone in the prevention of venous thromboembolism after elective neurosurgery.
    Agnelli G, Piovella F, Buoncristiani P, Severi P, Pini M, D'Angelo A, Beltrametti C, Damiani M, Andrioli GC, Pugliese R, Iorio A, Brambilla G.
    N Engl J Med; 1998 Jul 09; 339(2):80-5. PubMed ID: 9654538
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.